Abstract
The peptide-linked copper chelators CPTA-triglycyl-L-p-isothiocyanato-phenylalanine (CPTA-R1-NCS) as well as DOTA-triglycyl-L-p-isocyanato-phenylalanine (DOTA-R1-NCS) were synthesized and coupled to F(ab')2 fragments of the anti-neuroblastoma monoclonal antibody (MAb) chCE7. 67Cu-labeled conjugates were compared with the original CPTA- and DO3A-F(ab')2 in vitro and in vivo in mice bearing neuroblastoma xenografts. With the CPTA-R1-F(ab')2, biodistributions were improved, because radioactivity present in the kidney was reduced. With the DOTA-R1-F(ab')2, clearance from the blood was slower and tumor uptake was higher compared with the other conjugates. DOTA-R1-F(ab')2 achieved the best tumor/tissue ratios.
MeSH terms
-
Animals
-
Antibodies, Monoclonal / chemistry
-
Antibodies, Monoclonal / pharmacokinetics*
-
Brain Neoplasms / metabolism*
-
Chromatography, Gel
-
Chromatography, High Pressure Liquid
-
Chromatography, Thin Layer
-
Copper Radioisotopes
-
Humans
-
Immunoconjugates / chemistry
-
Immunoconjugates / pharmacokinetics
-
Immunoglobulin Fab Fragments / chemistry*
-
Ligands
-
Mice
-
Mice, Nude
-
Neoplasm Transplantation
-
Neuroblastoma / metabolism*
-
Oligopeptides / chemistry*
-
Radiopharmaceuticals / chemistry
-
Radiopharmaceuticals / pharmacokinetics*
-
Spectrophotometry, Ultraviolet
-
Tissue Distribution
Substances
-
Antibodies, Monoclonal
-
Copper Radioisotopes
-
Immunoconjugates
-
Immunoglobulin Fab Fragments
-
Ligands
-
Oligopeptides
-
Radiopharmaceuticals
-
glycyl-glycyl-glycine